- Corporate Officers - M
- Mott David M
Insider Trading History of Mott David M
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Mott David M since 2015.
This trader's CIK number is 1219871.
At the time of last reporting, Mott David M was the Officer of Ardelyx, Inc.. (stock ticker symbol ARDX).
Also see all insider trading activities at Ardelyx, Inc..
Note that in the past
MOTT DAVID M also reported insider trading activities as an insider of the following companies:
Insider Activities at Ardelyx, Inc. (ARDX)
Insider Activities at Novavax Inc (NVAX)
Insider Activities at Enliven Therapeutics, Inc. (ELVN)
Insider Activities at Epizyme, Inc. (EPZM)
Insider Activities at Mersana Therapeutics, Inc. (MRSN)
Insider Activities at Adaptimmune Therapeutics Plc (ADAP)
Insider Activities at Mirum Pharmaceuticals, Inc. (MIRM)
Insider Activities at Genocea Biosciences, Inc. (GNCA)
Insider Activities at Trevi Therapeutics, Inc. (TRVI)
Insider Activities at Regulus Therapeutics Inc. (RGLS)
Insider Activities at Aveo Pharmaceuticals, Inc. (AVEO)
Insider Activities at Surface Oncology, Inc. (SURF)
Insider Activities at Tesaro, Inc. (TSRO)
Insider Activities at Oruka Therapeutics, Inc. (ORKA)
Insider Activities at Appian Corp (APPN)
Insider Activities at Rhythm Pharmaceuticals, Inc. (RYTM)
Insider Activities at Achaogen, Inc. (AKAO)
Insider Activities at Tracon Pharmaceuticals, Inc. (TCON)
Insider Activities at Ra Pharmaceuticals, Inc. (RARX)
Insider Activities at Interleukin Genetics Inc (ILI)
Insider Activities at Synlogic, Inc. (SYBX)
Yearly summary of insider trading at Ra Pharmaceuticals, Inc. (RARX) by Mott David M
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2016 | RARX | 338,462 | $4,400,006 | 435 | $5,655 | 0 | $0 |
Yearly summary of insider trading at Aveo Pharmaceuticals, Inc. (AVEO) by Mott David M
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2019 | AVEO | 4,347,827 | $4,956,522 | 0 | $0 | 0 | $0 |
2018 | AVEO | 4,533,344 | $9,165,584 | 0 | $0 | 0 | $0 |
2017 | AVEO | 6,000,000 | $3,000,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Rhythm Pharmaceuticals, Inc. (RYTM) by Mott David M
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2017 | RYTM | 550,000 | $9,350,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Adaptimmune Therapeutics Plc (ADAP) by Mott David M
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2020 | ADAP | 7,500,000 | $5,002,500 | 0 | $0 | 0 | $0 |
2018 | ADAP | 22,839,672 | $40,012,335 | 0 | $0 | 0 | $0 |
2017 | ADAP | 12,870,000 | $9,009,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Achaogen, Inc. (AKAO) by Mott David M
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2016 | AKAO | 500,000 | $6,750,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Novavax Inc (NVAX) by Mott David M
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2025 | NVAX | 0 | $0 | 0 | $0 | 10,420 | $0 |
2024 | NVAX | 0 | $0 | 0 | $0 | 6,670 | $0 |
2023 | NVAX | 0 | $0 | 0 | $0 | 3,100 | $0 |
2022 | NVAX | 0 | $0 | 0 | $0 | 700 | $0 |
2021 | NVAX | 0 | $0 | 24,961 | $6,326,065 | 0 | $0 |
Yearly summary of insider trading at Genocea Biosciences, Inc. (GNCA) by Mott David M
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2019 | GNCA | 12,805,411 | $14,685,631 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Enliven Therapeutics, Inc. (IMRA) by Mott David M
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2022 | IMRA | 229,224 | $313,583 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Tracon Pharmaceuticals, Inc. (TCON) by Mott David M
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2016 | TCON | 869,565 | $4,999,998 | 0 | $0 | 0 | $0 |
2015 | TCON | 500,000 | $5,000,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Regulus Therapeutics Inc. (RGLS) by Mott David M
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2019 | RGLS | 1,136,704 | $1,227,640 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Appian Corp (APPN) by Mott David M
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2017 | APPN | 0 | $0 | 3,390,136 | $66,073,749 | 0 | $0 |
Yearly summary of insider trading at Synlogic, Inc. (MIRN) by Mott David M
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2015 | MIRN | 857,142 | $5,999,994 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Tesaro, Inc. (TSRO) by Mott David M
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2018 | TSRO | 145,532 | $8,386,945 | 0 | $0 | 0 | $0 |
2016 | TSRO | 1,420,858 | $49,999,993 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Oruka Therapeutics, Inc. (ABIO) by Mott David M
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2018 | ABIO | 0 | $0 | 1,460,209 | $731,564 | 0 | $0 |
Yearly summary of insider trading at Surface Oncology, Inc. (SURF) by Mott David M
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2018 | SURF | 133,333 | $1,999,995 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Epizyme, Inc. (EPZM) by Mott David M
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2021 | EPZM | 62,717 | $497,205 | 0 | $0 | 0 | $0 |
2020 | EPZM | 62,019 | $994,164 | 0 | $0 | 0 | $0 |
2019 | EPZM | 0 | $0 | 157,417 | $2,024,958 | 0 | $0 |
2018 | EPZM | 416,667 | $3,750,003 | 0 | $0 | 0 | $0 |
2017 | EPZM | 200,000 | $3,050,000 | 0 | $0 | 0 | $0 |
2016 | EPZM | 1,111,111 | $9,999,999 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Ardelyx, Inc. (ARDX) by Mott David M
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2025 | ARDX | 1,158,106 | $4,784,370 | 0 | $0 | 0 | $0 |
2024 | ARDX | 215,868 | $996,662 | 0 | $0 | 0 | $0 |
2022 | ARDX | 1,701,000 | $3,002,265 | 0 | $0 | 0 | $0 |
2020 | ARDX | 315,644 | $1,998,216 | 0 | $0 | 0 | $0 |
2016 | ARDX | 2,527,301 | $23,333,337 | 0 | $0 | 0 | $0 |
2015 | ARDX | 2,803,738 | $29,999,996 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Trevi Therapeutics, Inc. (TRVI) by Mott David M
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2019 | TRVI | 2,500,000 | $25,000,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Interleukin Genetics Inc (ILIU) by Mott David M
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2016 | ILIU | 20,120,724 | $1,991,951 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Mirum Pharmaceuticals, Inc. (MIRM) by Mott David M
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2019 | MIRM | 450,000 | $6,750,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Mersana Therapeutics, Inc. (MRSN) by Mott David M
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2020 | MRSN | 538,599 | $3,010,768 | 0 | $0 | 0 | $0 |
2019 | MRSN | 3,750,000 | $15,000,000 | 0 | $0 | 0 | $0 |
2017 | MRSN | 1,000,000 | $15,000,000 | 0 | $0 | 0 | $0 |
Insider trading activities at 21 companies by Mott David M:
1. Ra Pharmaceuticals, Inc. (RARX)
2. Aveo Pharmaceuticals, Inc. (AVEO)
3. Rhythm Pharmaceuticals, Inc. (RYTM)
4. Adaptimmune Therapeutics Plc (ADAP)
5. Achaogen, Inc. (AKAO)
6. Novavax Inc (NVAX)
7. Genocea Biosciences, Inc. (GNCA)
8. Enliven Therapeutics, Inc. (IMRA)
9. Tracon Pharmaceuticals, Inc. (TCON)
10. Regulus Therapeutics Inc. (RGLS)
11. Appian Corp (APPN)
12. Synlogic, Inc. (MIRN)
13. Tesaro, Inc. (TSRO)
14. Oruka Therapeutics, Inc. (ABIO)
15. Surface Oncology, Inc. (SURF)
16. Epizyme, Inc. (EPZM)
17. Ardelyx, Inc. (ARDX)
18. Trevi Therapeutics, Inc. (TRVI)
19. Interleukin Genetics Inc (ILIU)
20. Mirum Pharmaceuticals, Inc. (MIRM)
21. Mersana Therapeutics, Inc. (MRSN)
Table 1. Insider trading of Ra Pharmaceuticals, Inc. (RARX) by Mott David M
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2016-10-31 | RARX | Sale | 435 | 13.00 | 5,655 |
2016-10-31 | RARX | Buy | 338,462 | 13.00 | 4,400,006 |
Table 2. Insider trading of Aveo Pharmaceuticals, Inc. (AVEO) by Mott David M
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2019-04-08 | AVEO | Buy | 4,347,827 | 1.14 | 4,956,522 |
2018-12-20 | AVEO | Buy | 200,000 | 1.63 | 326,000 |
2018-12-21 | AVEO | Buy | 300,000 | 1.50 | 448,500 |
2018-12-11 | AVEO | Buy | 61,200 | 1.98 | 121,114 |
2018-12-07 | AVEO | Buy | 117,100 | 1.98 | 232,326 |
2018-12-10 | AVEO | Buy | 26,000 | 1.98 | 51,584 |
2018-12-06 | AVEO | Buy | 27,300 | 1.99 | 54,408 |
2018-11-28 | AVEO | Buy | 24,500 | 1.99 | 48,828 |
2018-11-30 | AVEO | Buy | 71,900 | 1.98 | 142,074 |
2018-11-20 | AVEO | Buy | 170,000 | 1.98 | 336,090 |
2018-11-15 | AVEO | Buy | 340,000 | 1.86 | 632,060 |
2018-11-16 | AVEO | Buy | 350,000 | 1.85 | 649,250 |
2018-11-19 | AVEO | Buy | 510,000 | 1.88 | 956,760 |
2018-08-21 | AVEO | Buy | 663,716 | 2.26 | 1,499,998 |
2018-07-18 | AVEO | Buy | 200,000 | 1.95 | 390,600 |
2018-07-19 | AVEO | Buy | 50,600 | 2.00 | 101,149 |
2018-06-27 | AVEO | Buy | 5,295 | 2.15 | 11,384 |
2018-06-28 | AVEO | Buy | 187,130 | 2.10 | 392,785 |
2018-05-30 | AVEO | Buy | 275 | 2.15 | 591 |
2018-05-21 | AVEO | Buy | 32,200 | 2.15 | 69,069 |
2018-05-18 | AVEO | Buy | 20,100 | 2.14 | 42,933 |
2018-05-17 | AVEO | Buy | 184,179 | 2.12 | 391,380 |
2018-05-08 | AVEO | Buy | 70,873 | 2.13 | 151,242 |
2018-04-06 | AVEO | Buy | 685,676 | 2.24 | 1,537,285 |
2018-04-09 | AVEO | Buy | 32,100 | 2.43 | 78,099 |
2018-04-10 | AVEO | Buy | 203,200 | 2.46 | 500,075 |
2017-03-28 | AVEO | Buy | 6,000,000 | .50 | 3,000,000 |
Table 3. Insider trading of Rhythm Pharmaceuticals, Inc. (RYTM) by Mott David M
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2017-10-10 | RYTM | Buy | 550,000 | 17.00 | 9,350,000 |
Table 4. Insider trading of Adaptimmune Therapeutics Plc (ADAP) by Mott David M
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2020-01-24 | ADAP | Buy | 7,500,000 | .67 | 5,002,500 |
2018-09-07 | ADAP | Buy | 15,000,000 | 1.67 | 25,005,000 |
2018-03-27 | ADAP | Buy | 6,000,000 | 1.92 | 11,502,000 |
2018-03-26 | ADAP | Buy | 571,164 | 1.90 | 1,087,496 |
2018-03-22 | ADAP | Buy | 869,574 | 1.90 | 1,655,668 |
2018-03-23 | ADAP | Buy | 294,090 | 1.95 | 572,299 |
2018-03-21 | ADAP | Buy | 104,844 | 1.81 | 189,872 |
2017-03-27 | ADAP | Buy | 12,870,000 | .70 | 9,009,000 |
Table 5. Insider trading of Achaogen, Inc. (AKAO) by Mott David M
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2016-12-19 | AKAO | Buy | 500,000 | 13.50 | 6,750,000 |
Table 6. Insider trading of Novavax Inc (NVAX) by Mott David M
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2025-06-12 | NVAX | Option Ex | 10,420 | .00 | 0 |
2024-06-12 | NVAX | Option Ex | 6,670 | .00 | 0 |
2023-06-10 | NVAX | Option Ex | 3,100 | .00 | 0 |
2022-06-17 | NVAX | Option Ex | 700 | .00 | 0 |
2021-09-23 | NVAX | Sale | 24,961 | 253.44 | 6,326,065 |
Table 7. Insider trading of Genocea Biosciences, Inc. (GNCA) by Mott David M
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2019-06-24 | GNCA | Buy | 2,857,142 | 3.50 | 9,999,997 |
2019-02-14 | GNCA | Buy | 9,948,269 | .47 | 4,685,634 |
Table 8. Insider trading of Enliven Therapeutics, Inc. (IMRA) by Mott David M
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2022-02-18 | IMRA | Buy | 50,398 | 1.30 | 65,517 |
2022-02-22 | IMRA | Buy | 65,817 | 1.56 | 102,674 |
2022-02-23 | IMRA | Buy | 35,257 | 1.46 | 51,475 |
2022-02-15 | IMRA | Buy | 19,552 | 1.20 | 23,462 |
2022-02-16 | IMRA | Buy | 11,779 | 1.20 | 14,134 |
2022-02-17 | IMRA | Buy | 14,595 | 1.17 | 17,076 |
2022-02-10 | IMRA | Buy | 8,753 | 1.29 | 11,291 |
2022-02-11 | IMRA | Buy | 14,573 | 1.23 | 17,924 |
2022-02-14 | IMRA | Buy | 8,500 | 1.18 | 10,030 |
Table 9. Insider trading of Tracon Pharmaceuticals, Inc. (TCON) by Mott David M
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2016-11-29 | TCON | Buy | 869,565 | 5.75 | 4,999,998 |
2015-02-04 | TCON | Buy | 500,000 | 10.00 | 5,000,000 |
Table 10. Insider trading of Regulus Therapeutics Inc. (RGLS) by Mott David M
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2019-05-07 | RGLS | Buy | 1,136,704 | 1.08 | 1,227,640 |
Table 11. Insider trading of Appian Corp (APPN) by Mott David M
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2017-11-27 | APPN | Sale | 569,620 | 19.49 | 11,101,893 |
2017-11-20 | APPN | Sale | 2,820,516 | 19.49 | 54,971,856 |
Table 12. Insider trading of Synlogic, Inc. (MIRN) by Mott David M
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2015-10-06 | MIRN | Buy | 857,142 | 7.00 | 5,999,994 |
Table 13. Insider trading of Tesaro, Inc. (TSRO) by Mott David M
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2018-03-02 | TSRO | Buy | 68,302 | 55.83 | 3,813,573 |
2018-03-05 | TSRO | Buy | 61,437 | 59.06 | 3,628,714 |
2018-03-06 | TSRO | Buy | 15,793 | 59.81 | 944,658 |
2016-03-18 | TSRO | Buy | 1,420,858 | 35.19 | 49,999,993 |
Table 14. Insider trading of Oruka Therapeutics, Inc. (ABIO) by Mott David M
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2018-02-26 | ABIO | Sale | 1,460,209 | .50 | 731,564 |
Table 15. Insider trading of Surface Oncology, Inc. (SURF) by Mott David M
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2018-04-23 | SURF | Buy | 133,333 | 15.00 | 1,999,995 |
Table 16. Insider trading of Epizyme, Inc. (EPZM) by Mott David M
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2021-03-25 | EPZM | Buy | 28,231 | 7.98 | 225,283 |
2021-03-26 | EPZM | Buy | 34,486 | 7.88 | 271,922 |
2020-06-26 | EPZM | Buy | 62,019 | 16.03 | 994,164 |
2019-06-27 | EPZM | Sale | 52,473 | 12.43 | 652,134 |
2019-06-26 | EPZM | Sale | 52,472 | 12.85 | 674,160 |
2019-06-25 | EPZM | Sale | 52,472 | 13.31 | 698,664 |
2018-10-05 | EPZM | Buy | 416,667 | 9.00 | 3,750,003 |
2017-09-18 | EPZM | Buy | 200,000 | 15.25 | 3,050,000 |
2016-01-12 | EPZM | Buy | 1,111,111 | 9.00 | 9,999,999 |
Table 17. Insider trading of Ardelyx, Inc. (ARDX) by Mott David M
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2025-06-16 | ARDX | Buy | 200,000 | 3.63 | 725,800 |
2025-06-09 | ARDX | Buy | 200,000 | 3.69 | 737,200 |
2025-05-15 | ARDX | Buy | 100,000 | 3.29 | 329,100 |
2025-05-02 | ARDX | Buy | 381,377 | 4.22 | 1,610,936 |
2025-02-24 | ARDX | Buy | 77,729 | 5.00 | 388,722 |
2025-01-21 | ARDX | Buy | 199,000 | 4.99 | 992,612 |
2024-11-13 | ARDX | Buy | 215,868 | 4.62 | 996,662 |
2022-11-17 | ARDX | Buy | 567,000 | 1.76 | 1,000,755 |
2022-11-17 | ARDX | Buy | 567,000 | 1.76 | 1,000,755 |
2022-11-17 | ARDX | Buy | 567,000 | 1.76 | 1,000,755 |
2020-12-10 | ARDX | Buy | 170,000 | 5.89 | 1,000,789 |
2020-06-24 | ARDX | Buy | 72,598 | 6.75 | 489,891 |
2020-06-25 | ARDX | Buy | 68,373 | 6.96 | 476,012 |
2020-06-22 | ARDX | Buy | 4,673 | 6.75 | 31,524 |
2016-07-18 | ARDX | Buy | 1,527,301 | 8.73 | 13,333,337 |
2016-01-13 | ARDX | Buy | 1,000,000 | 10.00 | 10,000,000 |
2015-06-05 | ARDX | Buy | 2,803,738 | 10.70 | 29,999,996 |
Table 18. Insider trading of Trevi Therapeutics, Inc. (TRVI) by Mott David M
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2019-05-09 | TRVI | Buy | 2,500,000 | 10.00 | 25,000,000 |
Table 19. Insider trading of Interleukin Genetics Inc (ILIU) by Mott David M
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2016-07-29 | ILIU | Buy | 20,120,724 | .10 | 1,991,951 |
Table 20. Insider trading of Mirum Pharmaceuticals, Inc. (MIRM) by Mott David M
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2019-07-22 | MIRM | Buy | 450,000 | 15.00 | 6,750,000 |
Table 21. Insider trading of Mersana Therapeutics, Inc. (MRSN) by Mott David M
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2020-04-07 | MRSN | Buy | 538,599 | 5.59 | 3,010,768 |
2019-03-05 | MRSN | Buy | 3,750,000 | 4.00 | 15,000,000 |
2017-07-03 | MRSN | Buy | 1,000,000 | 15.00 | 15,000,000 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Mott David M
(Officer of Ardelyx, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.